Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma

Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma

Introduction: While epidermal growth factor receptor (EGFR) inhibitors have improved progression-free survival in patients with non-small cell lung cancer (NSCLC), one of the most common adverse effects is papulopustular skin eruption, which is frequently severe enough to be treated with oral minocy...

Full description

Bibliographic Details
Main Authors: Ann T. Bell, John W. Roman, Max L. Gratrix, Christina E. Brzezniak
Format: Article
Language:English
Published: Karger Publishers 2017-02-01
Series:Case Reports in Oncology
Subjects:
Epidermal growth factor receptor inhibitor
Papulopustular eruption
Minocycline
Drug toxicity
Doxycycline
Online Access:http://www.karger.com/Article/FullText/452146

Internet

http://www.karger.com/Article/FullText/452146

Similar Items